2021
DOI: 10.1016/j.smrv.2020.101409
|View full text |Cite
|
Sign up to set email alerts
|

Sleep disorders and cancer: State of the art and future perspectives

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
101
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 133 publications
(128 citation statements)
references
References 109 publications
3
101
0
Order By: Relevance
“…Sleep problems are among the most frequently reported complaints in cancer patients across all stages of the disease (i.e., before, during, and after treatment) [1,2]. This issue has received research attention in patients with solid tumors but has rarely been investigated in hematological cancer patients [3][4][5].…”
Section: Introductionmentioning
confidence: 99%
“…Sleep problems are among the most frequently reported complaints in cancer patients across all stages of the disease (i.e., before, during, and after treatment) [1,2]. This issue has received research attention in patients with solid tumors but has rarely been investigated in hematological cancer patients [3][4][5].…”
Section: Introductionmentioning
confidence: 99%
“…The treatment of cancer lies not only in the disease itself and prolonging survival time, but also in improving quality of life (10,11). Long-term continuous negative emotions will affect the endocrine system, central nervous system, and other functions, causing many undesirable consequences (12,13).…”
Section: Discussionmentioning
confidence: 99%
“…In recent years, a series of studies have been conducted on the role of orexins not only in the field of sleep disorders but also in oncology, discovering that modulation of the orexin signaling may also unexpectedly play a therapeutic role in the treatment of some types of cancer [ 120 , 121 ]. One study demonstrated that OXA stimulates neovascularization [ 122 ].…”
Section: Orexin Cancer and Neurodegenerative Diseasesmentioning
confidence: 99%
“…More recent data on human colon cancer cell lines indicate that OXA induces autophagy [ 127 ] and that dual-agonist occupancy of OR1 and cholecystokinin A receptor heterodimers decreases migration [ 128 ]. Orexin-dependent apoptosis might be mediated by two immunoreceptor tyrosine-based inhibitory motifs in both OR1 and OR2, involvement of the phosphotyrosine phosphatase SHP2, and induction of mitochondrial apoptosis [ 120 ].…”
Section: Orexin Cancer and Neurodegenerative Diseasesmentioning
confidence: 99%